Hospital law - like pharmaceutical law - is increasingly suffering from a lack of studies and specialists in this field. This observation (which continues to be verified) has led several members of the team to invest in this axis. Unlike axis 1, axis 2 has been the object of a more recent investment. As such, it does not have the precedence of the other study themes.
Hospital law can be qualified as the second marker of the team's disciplinary visibility. The works and manuals on this theme have been particularly praised. In recent years, hospital law has given rise to reflections on the organization of the health care system, on the mechanisms of financing and on liability. In the last few months, the subject has been in full mutation and the team has been able to take advantage of it to propose innovative publications.